Workflow
Amdocs Q2 Earnings Top Estimates, Stock Falls on Dim Q3 Profit Outlook
DOXAmdocs(DOX) ZACKS·2025-05-08 10:45

Core Insights - Amdocs Limited (DOX) reported better-than-expected second-quarter fiscal 2025 results with non-GAAP earnings of 1.78pershare,exceedingmanagementsguidanceandincreasing14.11.78 per share, exceeding management's guidance and increasing 14.1% year over year [1][2] - The company's revenues for the second quarter were 1.23 billion, surpassing the consensus estimate but down 9.4% year over year due to the phase-out of certain business activities [2][4] Financial Performance - Amdocs' earnings surpassed the Zacks Consensus Estimate in three of the last four quarters, with an average surprise of 0.1% [2] - Managed services revenues rose 3.7% year over year to 747million,whilethenonGAAPoperatingincomeincreased4.7747 million, while the non-GAAP operating income increased 4.7% year over year to 240.1 million, with an operating margin expansion of 290 basis points to 21.3% [6] - The company ended the second quarter with a backlog of 4.17billion,up4.17 billion, up 30 million sequentially [6] Regional Revenue Breakdown - North America generated revenues of 738.3million,accountingfor65738.3 million, accounting for 65% of total revenues, but saw a decline of 10.3% year over year [4] - Europe revenues, making up 16% of total revenues, decreased 2.2% year over year to 180.7 million [5] - Rest of the World (RoW) revenues, which represent 19% of total revenues, declined 12% year over year to 209.2million[5]GuidanceandOutlookForthethirdquarter,Amdocsexpectsrevenuesbetween209.2 million [5] Guidance and Outlook - For the third quarter, Amdocs expects revenues between 1.11 billion and 1.15billion,withamidpointof1.15 billion, with a midpoint of 1.13 billion, indicating a year-over-year decline of 9.3% [8] - Non-GAAP earnings per share guidance for the third quarter is set between 1.68and1.68 and 1.74, below the Zacks Consensus Estimate of 1.75[9]Forfiscal2025,thecompanyreviseditsrevenuedeclinerateguidanceto9.110.91.75 [9] - For fiscal 2025, the company revised its revenue decline rate guidance to 9.1-10.9% from a previous forecast of 8.4-11.6% [9][10] Balance Sheet and Cash Flow - As of March 31, 2025, Amdocs had cash and short-term investments of 324 million, down from 349millionattheendof2024[7]Thecompanygeneratedoperatingcashflowof349 million at the end of 2024 [7] - The company generated operating cash flow of 172 million and free cash flow of $156 million during the second quarter [7]